References

1. Graf WD, Nagel SK, Epstein LG, et al. Pediatric neuroenhancement: Ethical, legal, social, and neurodevelopmental implications. Neurology. 2013 Mar 26;80(13):1251-1260.

2. Repantis D, Laisney O, Heuser I. Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res. 2010;61(6):473-481.

3. Repantis D, Schlattmann P, Laisney O, Heuser I. Antidepressants for neuroenhancement in healthy individuals: a systematic review. (2008) Available at: https://www.empr.com/home/features/can-pediatric-neuroenhancement-be-justified/. Accessed: April 4, 2013.

4. Repantis D, Schlattmann P, Laisney O, Heuser I. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res. 2010 Sep;62(3):187-206.


Continue Reading

5. Larriviere D, Williams MA, Rizzo M, et al. Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee. Neurology. 2009. 27;73(17):1406-12.

6. Boot BP, Partridge B, Hall W. Better evidence for safety and efficacy is needed before neurologists prescribe drugs for neuroenhancement to healthy people. Neurocase. 2012;18(3):181-184.

7. Heinz A, Kipke R, Heimann H, Wiesing U. Cognitive neuroenhancement: false assumptions in the ethical debate. J Med Ethics. 2012;38(10):605-608.

8. Greely H, Sahakian B, Harris J, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature. 2008;456:701-705.

9. Beauchamp TL, Childress JF. Principles of Biomedical Ethics, 6th ed. New York, NY: Oxford University Press, 2008.

TAKE OUR POLL!

Do you think neuro-enhancement is justifiable in certain cases?